Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
218 studies found for:    "Idiopathic pulmonary fibrosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
2 Recruiting Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Omeprazole;   Drug: Matched placebo
3 Unknown  Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Behavioral: Pulmonary Rehabilitation
4 Recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
5 Recruiting Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
6 Recruiting Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Hyperpolarized 129-Xenon gas;   Device: MRI
7 Completed
Has Results
Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: ACT-064992 (macitentan);   Drug: Placebo
8 Unknown  The Role of Gastric Content Microaspirations in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Condition: IDIOPATHIC PULMONARY FIBROSIS
Intervention:
9 Unknown  Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: minocycline
10 Completed
Has Results
A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Placental MSC
11 Withdrawn A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Standard Steroid Treatment;   Drug: The Standard Steroid Treatment, Plasma Exchange and rituximab
12 Recruiting Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Biological: Endobronchial infusion of adult mesenchymal stem cells;   Biological: Autologous mesenchymal stem cells derived from bone marrow
13 Not yet recruiting Yoga Effect on Quality of Life Study Among Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Yoga
14 Active, not recruiting The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Cough monitor
15 Completed Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Standard pulmonary rehabilitation program
16 Recruiting Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Cotrimoxazole;   Drug: Placebo
17 Withdrawn Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Macitentan
18 Completed Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
19 Recruiting Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
20 Recruiting A Safety and Tolerability Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Pirfenidone;   Drug: Vismodegib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.